IMGT Co., Ltd.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Chemotherapy With or Without IMD10 (Focused Ultrasound) in the Treatment of Borderline Resectable or Locally Advanced Pancreatic Cancer (NCT07325214) | IMGT Co., Ltd. | 2026-09-01 |
Track IMGT Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.